🔎 Trials Near Me

Home › Kanser sa Cervix › Tennessee › Nashville

Pag-aaral pangklinika para sa Kanser sa Cervix sa Nashville, TN

19 pag-aaral para sa Kanser sa Cervix ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Nashville (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Nagre-recruitPhase 1
  • Sarah Cannon Research Institute, Nashville
  • Tennessee Oncology PLLC, Nashville
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06465069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 2
  • SCRI Oncology Partners, Nashville
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06172478

DESTINY-PANTUMOUR04

Nagre-recruitObservasyonal na pag-aaral
  • Research Site, Nashville
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07124000

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Nagre-recruitPhase 1/2
  • Vanderbilt University Medical Center, Nashville
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Nagre-recruitPhase 1
  • Sarah Cannon - Tennessee Oncology, Nashville
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05983432

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Nagre-recruitPhase 1/2
  • Sarah Cannon Nashville, Nashville
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07109726

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Nagre-recruitPhase 1
  • Sarah Cannon Research Institute, Nashville
Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06293898

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Nagre-recruitPhase 1
  • Normunity Investigational Site, Nashville
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07182149

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2
  • Vanderbilt University Medical Center, Nashville
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT04895709

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2
  • Sarah Cannon Research Institute Oncology Partners (SCRI-Nashville), Nashville
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05592626

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Nagre-recruitPhase 1/2
  • SCRI Oncology Partners, Nashville
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06330064

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2
  • Sarah Cannon Research Institute, Nashville
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT05768139

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Nagre-recruitPhase 1
  • US Oncology Research LLC, Nashville
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT04389632

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Nagre-recruitPhase 1/2
  • Sarah Cannon Research Institute, Nashville
Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT06239194

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • Vanderbilt-Ingram Cancer Center, Nashville
Edad 40 pataas · Lahat ng kasarian · Na-update Ene 20, 2026 · NCT05366881

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Nagre-recruitPhase 1/2
  • Research Site 136, Nashville
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 21, 2025 · NCT05914116

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral
  • Massive Bio SYNERGY-AI site, Nashville
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Nagre-recruitPhase 1/2
  • Tennessee Oncology, Nashville
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2025 · NCT05941507

Pag-aaral para sa Kanser sa Cervix sa ibang lungsod

Iba pang pag-aaral sa Nashville

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.